{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:30:15Z","timestamp":1776853815198,"version":"3.51.2"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["CSD2010-00065"],"award-info":[{"award-number":["CSD2010-00065"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2013-48971-C2-1-R"],"award-info":[{"award-number":["SAF2013-48971-C2-1-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijpddr.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T12:33:11Z","timestamp":1553862791000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Insights into Chagas treatment based on the potential of bacteriocin AS-48"],"prefix":"10.1016","volume":"10","author":[{"given":"Rub\u00e9n","family":"Mart\u00edn-Escolano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Cebri\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Mart\u00edn-Escolano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Maqueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"S\u00e1nchez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clotilde","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2019.03.003_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/09298665113206660099","article-title":"IMAP 2012: antimicrobial peptides to combat (multi)drug-resistant pathogens","volume":"21","author":"Adermann","year":"2014","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02288-16","article-title":"Enterocin AS-48 as evidence for the use of bacteriocins as new leishmanicidal agents","volume":"61","author":"Abeng\u00f3zar","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.toxicon.2013.03.011","article-title":"Melittin peptide kills Trypanosoma cruzi parasites by inducing different cell death pathways","volume":"69","author":"Adade","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib4","article-title":"Synergy between circular bacteriocin AS-48 and ethambutol against","volume":"62","author":"Aguilar-P\u00e9rez","year":"2018","journal-title":"Mycobacterium tuberculosis. Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/S0074-02762000000100016","article-title":"Lipids shed into the culture medium by trypomastigotes of Trypanosoma cruzi","volume":"95","author":"Agusti","year":"2000","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib6","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1074\/jbc.M109874200","article-title":"Trialysin, a novel pore-forming protein from saliva of hematophagous insects activated by limited proteolysis","volume":"277","author":"Amino","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.idairyj.2008.02.001","article-title":"Optimization of enterocin AS-48 production on a whey-based substrate","volume":"18","author":"Ananou","year":"2008","journal-title":"Int. Dairy J."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130165","article-title":"Trypanosoma cruzi intracellular amastigotes isolated by nitrogen decompression are capable of endocytosis and cargo storage in reservosomes","volume":"10","author":"Batista","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2006.03.017","article-title":"Energy metabolism of trypanosomatids: adaptation to available carbon sources","volume":"149","author":"Bringaud","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib11","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1038\/cddiscovery.2016.92","article-title":"A homolog of cyclophilin D is expressed in Trypanosoma cruzi and is involved in the oxidative stress-damage response","volume":"3","author":"Bustos","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molbiopara.2014.01.002","article-title":"Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert","volume":"193","author":"Campos","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.fm.2011.12.002","article-title":"Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain","volume":"30","author":"Cebri\u00e1n","year":"2012","journal-title":"Food Microbiol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jsb.2015.03.006","article-title":"The bacteriocin AS-48 requires dimer dissociation followed by hydrophobic interactions with the membrane for antibacterial activity","volume":"190","author":"Cebri\u00e1n","year":"2015","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib15","doi-asserted-by":"crossref","first-page":"11766","DOI":"10.1038\/s41598-018-29580-7","article-title":"Control of Propionibacterium acnes by natural antimicrobial substances: role of the bacteriocin AS-48 and lysozyme","volume":"8","author":"Cebri\u00e1n","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas Disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jmii.2016.12.005","article-title":"Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria","volume":"50","author":"Chung","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro2937","article-title":"Bacteriocins - a viable alternative to antibiotics?","volume":"11","author":"Cotter","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2174\/138161208784041123","article-title":"An introduction to the structural organization of parasitic protozoa","volume":"14","author":"De Souza","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S003118201300142X","article-title":"Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections","volume":"141","author":"Don","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1550-7408.1997.tb05734.x","article-title":"Comparative aspects of energy metabolism in plant trypanosomatids","volume":"44","author":"Fern\u00e1ndez-Becerra","year":"1997","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.exppara.2010.02.016","article-title":"Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts","volume":"125","author":"Fieck","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0923-2508(89)90060-0","article-title":"Bactericidal and bacteriolytic action of peptide antibiotic AS-48 against gram-positive and gram-negative bacteria and other organisms","volume":"140","author":"G\u00e1lvez","year":"1989","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijantimicag.2004.08.010","article-title":"In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum","volume":"25","author":"Gonz\u00e1lez","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1586\/14787210.5.6.951","article-title":"Alternative mechanism of action of cationic antimicrobial peptides on bacteria","volume":"5","author":"Hale","year":"2007","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2672.2012.05338.x","article-title":"Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance","volume":"113","author":"Hassan","year":"2012","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/AAC.47.2.607-613.2003","article-title":"NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi","volume":"47","author":"Jacobs","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib29","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/j.1460-2075.1990.tb07462.x","article-title":"Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase does not conform to the \u201chotspot\u201d topogenic signal model","volume":"9","author":"Kendall","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/dkw381","article-title":"Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides","volume":"72","author":"Kubicek-Sutherland","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41564-018-0164-0","article-title":"Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides","volume":"3","author":"L\u00e1z\u00e1r","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib32","doi-asserted-by":"crossref","first-page":"C195","DOI":"10.1152\/ajpcell.00641.2005","article-title":"A role for mitochondrial aquaporins in cellular life-and-death decisions?","volume":"291","author":"Lee","year":"2006","journal-title":"AJP Cell Physiol"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/AAC.37.1.148","article-title":"Neutralizing antibodies against the peptide antibiotic AS-48: immunocytological studies","volume":"37","author":"Maqueda","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/1389203043379567","article-title":"Peptide AS-48: prototype of a new class of cyclic bacteriocins","volume":"5","author":"Maqueda","year":"2004","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib35","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1021\/acs.jmedchem.8b00468","article-title":"Second generation of Mannich base-type derivatives with in vivo activity against Trypanosoma cruzi","volume":"61","author":"Mart\u00edn-Escolano","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpddr.2018.03.002","article-title":"Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48","volume":"8","author":"Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/jis331","article-title":"Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population","volume":"206","author":"Mejia","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.toxicon.2017.02.031","article-title":"Evaluation of the antichagasic activity of batroxicidin, a cathelicidin-related antimicrobial peptide found in Bothrops atrox venom gland","volume":"130","author":"Mello","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cbpa.2017.03.014","article-title":"Host defense antimicrobial peptides as antibiotics: design and application strategies","volume":"38","author":"Mishra","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2174\/138920111796117364","article-title":"Are bacteriocins underexploited? NOVEL applications for OLD antimicrobials","volume":"12","author":"Montalb\u00e1n-L\u00f3pez","year":"2011","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib41","doi-asserted-by":"crossref","first-page":"28734","DOI":"10.3402\/jev.v4.28734","article-title":"Vesicles from different Trypanosoma cruzi strains trigger differential innate and chronic immune responses","volume":"4","author":"Nogueira","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib42","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fmicb.2018.01143","article-title":"LAB bacteriocins controlling the food isolated (Drug-Resistant) staphylococci","volume":"9","author":"Perales-Ad\u00e1n","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20061281","article-title":"Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression","volume":"403","author":"Piacenza","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib44","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1078\/0171-9335-00112","article-title":"Trypanosoma cruzi epimastigote endocytic pathway: cargo enters the cytostome and passes through an early endosomal network before storage in reservosomes","volume":"79","author":"Porto-Carreiro","year":"2000","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib45","doi-asserted-by":"crossref","first-page":"37908","DOI":"10.1038\/srep37908","article-title":"Lipid-II independent antimicrobial mechanism of nisin depends on its crowding and degree of oligomerization","volume":"6","author":"Prince","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001932","article-title":"A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes","volume":"6","author":"Rycker","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jmb.2003.09.060","article-title":"Structure of bacteriocin AS-48: from soluble state to membrane bound state","volume":"334","author":"S\u00e1nchez-Barrena","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib48","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00018-011-0724-4","article-title":"AS-48 bacteriocin: close to perfection","volume":"68","author":"S\u00e1nchez-Hidalgo","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093936","article-title":"Trypanosoma cruzi cell death induced by the Morita-Baylis-Hillman Adduct 3-Hydroxy-2-Methylene-3-(4-Nitrophenylpropanenitrile)","volume":"9","author":"Sandes","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2164\/jandrol.108.005629","article-title":"Procyanidin induces apoptosis and necrosis of prostate cancer cell line PC-3 in a mitochondrion-dependent manner","volume":"30","author":"Shang","year":"2009","journal-title":"J. Androl."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib51","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jam.13033","article-title":"Biochemical applications of nisin","volume":"120","author":"Shin","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.molimm.2015.08.009","article-title":"Antimicrobial proteins: from old proteins, new tricks","volume":"68","author":"Smith","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib53","first-page":"152","article-title":"Cell death in amastigote forms of Leishmania amazonensis induced by parthenolide","volume":"14","author":"Tiuman","year":"2014"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exppara.2006.10.007","article-title":"Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction","volume":"116","author":"Verma","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jsb.2016.07.018","article-title":"Loss of the cytostome-cytopharynx and endocytic ability are late events in Trypanosoma cruzi metacyclogenesis","volume":"196","author":"Vidal","year":"2016","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib56","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.jacc.2010.02.030","article-title":"Phenyl-\u03b1-tert-butyl-nitrone and Benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic rats","volume":"55","author":"Wen","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib57","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib58","series-title":"Chagas Disease (American Trypanosomiasis)","author":"World Health Organization (WHO)","year":"2016"},{"key":"10.1016\/j.ijpddr.2019.03.003_bib59","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1128\/AAC.02434-15","article-title":"Combination effects of antimicrobial peptides","volume":"60","author":"Yu","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.03.003_bib60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.actatropica.2017.09.017","article-title":"Trypanosoma cruzi genetic diversity: something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity","volume":"184","author":"Zingales","year":"2018","journal-title":"Acta Trop."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:48:13Z","timestamp":1761922093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320719300417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":59,"alternative-id":["S2211320719300417"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.03.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into Chagas treatment based on the potential of bacteriocin AS-48","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}